Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Biorxiv : the Preprint Server for Biology|November 24, 2025
Co-targeting menin and LSD1 dismantles oncogenic programs and restores differentiation in MLL-rearranged AMLMina M Tayari, Helena Gomes Dos Santos, Felipe Beckedorff, et al.
Plos One|September 8, 2023
Human cardiovascular disease model predicts xanthine oxidase inhibitor cardiovascular riskRyan E Feaver, M Scott Bowers, Banumathi K Cole, et al.
Blood|August 5, 2022
Long-term outcomes in patients with relapsed or refractory hairy cell leukemia treated with vemurafenib monotherapyShivani Handa, Jeong-Ok Lee, Andriy Derkach, et al.
NPJ Precision Oncology|October 19, 2022
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14)Nina Nguyen, Sana Chaudhry, Tulasigeri M Totiger, et al.
The Lancet. Haematology|August 1, 2020
Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trialJustin Taylor, Xiaoli Mi, Alexander V Penson, et al.
Blood|July 9, 2020
Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasmsJustin Taylor, Xiaoli Mi, Khrystyna North, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Targeting an RNA Editor to Impede H3K27M+ Pediatric GliomasChristian K Ramsoomair, Victoria Alvarez, Felipe Sarmiento, et al.
Nature Communications|April 22, 2024
Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificityHidehiro Itonaga, Adnan K Mookhtiar, Sarah M Greenblatt, et al.
Blood|June 28, 2019
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmarkJustin Taylor, Michael Haddadin, Vivek A Upadhyay, et al.
Science Translational Medicine|January 3, 2024
Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AMLEmily C Wheeler, Benjamin J E Martin, William C Doyle, et al.
Pageof 15